BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18646558)

  • 1. Biological activity of amide derivatives of lysine.
    Midura-Nowaczek K; Lepietuszko I; Bruzgo I; Markowska A
    Acta Pol Pharm; 2008; 65(3):377-81. PubMed ID: 18646558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
    Midura-Nowaczek K; Lepietuszko I; Bruzgo I
    Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
    Purwin M; Bruzgo I; Markowska A; Midura-Nowaczek K
    Pharmazie; 2009 Nov; 64(11):765-7. PubMed ID: 20099524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of benzylamides of dipeptides as potential inhibitors of plasmin.
    Midura-Nowaczek K; Roszkowska-Jakimiec W; Lepietuszko I; Bruzgo I
    Pharmazie; 2003 Oct; 58(10):687-9. PubMed ID: 14609277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthetic inhibitors of serine proteinases. Part 24: Inhibition of trypsin, plasmin and thrombin by cyclic amides of N alpha-arylsulfonylamidinophenyl-glycines (author's transl)].
    Stürzebecher J; Markwardt F; Voigt B; Wagner G; Walsmann P
    Pharmazie; 1981; 36(7):501-2. PubMed ID: 6456466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hansch analysis of the inhibitory action of 3- and 4-substituted benzamidines on thrombin, plasmin and trypsin (author's transl)].
    Labes D; Hagen V
    Pharmazie; 1979 Oct; 34(10):649-53. PubMed ID: 161621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine.
    Salvagnini C; Gharbi S; Boxus T; Marchand-Brynaert J
    Eur J Med Chem; 2007 Jan; 42(1):37-53. PubMed ID: 17010480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
    Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
    Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis.
    Puckett LG; Lewis JK; Urbas A; Cui X; Gao D; Bachas LG
    Biosens Bioelectron; 2005 Mar; 20(9):1737-43. PubMed ID: 15681188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic serine proteinase inhibitors. 30. Synthesis of alpha-benzoylamino-4-amidinocinnamic acid and alpha-(4-amidinobenzoylamino) cinnamic acid amides, and their inhibitory effect on trypsin-like enzymes].
    Voigt B; Wagner G; Walsmann P; Stürzebecher J; Markwardt F
    Pharmazie; 1983 Dec; 38(12):835-8. PubMed ID: 6230681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free-Wilson analysis of the inhibitory effect of 4-substituted benzamidines on thrombin, plasmin and trypsin (author's transl)].
    Labes D; Hagen V
    Pharmazie; 1979; 34(9):554-6. PubMed ID: 161622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic inhibitors of serine proteinases. 31. The inhibition of trypsin, plasmin and thrombin by isomeric compounds of N alpha -arylsulfonylated omega-amidinophenyl-alpha-aminoalkylcarboxylic acid amides].
    Stürzebecher J; Markwardt F; Vieweg H; Wagner G; Walsmann P
    Pharmazie; 1984 Jun; 39(6):411-3. PubMed ID: 6237371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine.
    Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Okamoto S; Funahara Y; Hijikata A
    J Med Chem; 1980 Aug; 23(8):830-6. PubMed ID: 7401110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of some synthetic arginyl and lysyl compounds on clotting and fibrinolysis.
    Weinstein MJ; Doolittle RF
    Thromb Diath Haemorrh; 1972 Oct; 28(2):289-97. PubMed ID: 4639661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clotting and fibrinolytic activities in acute alcoholic golden hamsters with or without ether anaesthesia].
    Mizutani Y; Hishikawa-Itoh Y; Takashima E; Oguri T; Yamada T
    Nihon Hoigaku Zasshi; 1991 Apr; 45(2):146-54. PubMed ID: 1920921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular peptides as potential inhibitors of plasmin.
    Markowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2007; 64(4):355-8. PubMed ID: 18536161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide inhibitors of plasmin.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1990; 47(1-2):39-42. PubMed ID: 12959258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors.
    Weinstein MJ; Doolittle RF
    Biochim Biophys Acta; 1972 Feb; 258(2):577-90. PubMed ID: 4258697
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of short peptides containing lysine and epsilon-aminocaproic acid on fibrinolytic activity of plasmin and topoisomerase II action on supercoiled DNA.
    Midura-Nowaczek K; Purwin M; Markowska A; Drozdowska D; Bruzgo M
    Acta Pol Pharm; 2013; 70(3):431-4. PubMed ID: 23757933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.